Trademark Overview
On Monday, September 23, 2024, a trademark application was filed for ACCORD BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the ACCORD BIOPHARMA trademark a serial number of 98763913. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, September 23, 2024. This trademark is owned by Accord BioPharma, Inc.. The ACCORD BIOPHARMA trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Insurance & Financial Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:
Providing online non-downloadable videos featuring information regarding therapies and treatment options in the fields of Oncology, Immunology, and Critical Care
Downloadable software for managing medical office inventories of pharmaceutical preparations
Providing information and answers to questions for healthcare providers and patients about medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance; healthcare insurance services, namely, benefit verification services, prior authorization support and information, billing and claims processing support, and claims appeal support; providing information about healthcare insurance, patient financial assistance, and patient insurance reimbursement programs including enrollment requirements;
Providing on-line, non-downloadable, Internet-based software applications for providing, exchanging, retrieving and analyzing health and healthcare information; providing a website featuring technology enabling users to exchange, retrieve and analyze health and healthcare information; Providing medical and scientific research information in the nature of clinical and drug information to medical professionals for use in medical education in the field of oncology, immunology, and critical care; providing medical and scientific research information to medical professionals in the field of oncology, immunology, and critical care pharmaceuticals and clinical trials